Mezzanine fully exits BioVendor Group

The deal saw the GP selling its stake to Czech family office Consilium. At completion of the deal, the latter will own a majority stake, while the company's founder and CEO Viktor Ruzicka will retain a minority holding. Financial details surrounding the transaction remain undisclosed.

Previous funding
The fund manager acquired a minority stake in the business via its fund Accession Mezzanine Capital III, as part of a structured €10m series-A round of funding in January 2014. The deal included an €8m warranted loan to support eight acquisitions in Germany, Austria, the UK, the Czech Republic and Slovakia.

The business payed back the entire loan in December 2016, while the GP retained a stake in the business through its warrants until the sale.

Company
Founded in 1992, BioVendor is a developer of research and diagnostics products. The company is headquartered in Brno, Czech Republic.

People
Mezzanine Management – Chris Buckle (managing partner).

Advisers
Company – Wolf Theiss (legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Healthcare
• CEE
• Czech Republic